Maranda Bruno, Cousineau Jocelyne, Allard Pierre, Lambert Marie
Department of Pediatrics, Medical Genetics Division, Ste-Justine Hospital and Université de Montréal, 3175 Côte Ste-Catherine, Montréal, QC, Canada H3T 1C5.
Clin Biochem. 2007 May;40(8):531-5. doi: 10.1016/j.clinbiochem.2007.01.024. Epub 2007 Mar 12.
Plasma ammonia measurement is greatly influenced by pre-analytical conditions, which may lead to false positives. We wanted to evaluate the prevalence and clinical impact of plasma ammonia false positives in a pediatric population.
Over a 28-month period, charts of patients with elevated ammonemia were retrospectively reviewed to identify false positives defined as elevated concentrations that subsequently normalized without plausible explanation for the elevations.
1880 Ammonia measurements were available in 479 patients. Elevated results that subsequently normalized were found in 86 patients. Forty-one (48%) of these patients had most likely falsely elevated ammonemia. Additional blood sampling and laboratory testing were the most frequent consequences of false positives.
There is a high proportion of false positives among elevated plasma ammonia measurements. Capillary samples and delay between sampling and centrifugation are possible contributing factors. Clinical consequences of false positives were most often limited.
血浆氨测定受分析前条件的影响很大,这可能导致假阳性结果。我们旨在评估儿科人群中血浆氨假阳性的发生率及其临床影响。
在28个月的时间里,对氨血症升高患者的病历进行回顾性分析,以确定假阳性病例,即氨浓度升高但随后在无合理升高原因的情况下恢复正常的情况。
479例患者共进行了1880次氨测定。86例患者出现了随后恢复正常的升高结果。其中41例(48%)患者的氨血症很可能是假阳性升高。额外的血液采样和实验室检测是假阳性最常见的后果。
血浆氨测定结果升高时,假阳性比例较高。毛细血管采血样本以及采样与离心之间的延迟可能是促成因素。假阳性的临床后果通常较为有限。